MedTrace Logo

Studying the Impact of a Medication Use Evaluation by the Community Pharmacist

NCT03179722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 453

Last updated 2019-07-24

No results posted yet for this study

Summary

In this intervention study, 75 Belgian community pharmacies each recruit 12 patients for an intermediate medication review. For each patient, the identified drug-related problems and subsequent interventions are registered using the PharmDisc classification. In a subset of Dutch speaking patients, a pretest-posttest single group design is used to measure the impact of this review on patient related outcomes using questionnaires. The primary outcome is the medication related quality of life, measured via the living with medicines questionnaire. Other patient reported outcomes include adherence, self-management, patient satisfaction, fall incidents and use of emergency healthcare services. Medication records are also collected to objectively measure adherence before and after the intervention.

Conditions

  • Aging

Interventions

BEHAVIORAL

Medication review

The intervention consists of a medicines use review provided by community pharmacists in Belgium. A medicines use review is a medication review type 2a in which both a patient interview and dispensing data are used as information sources to identify drug-related problems with a specific focus on the medicines use of the patient.

BEHAVIORAL

Additional data collection: questionnaires

Pre-post study design. At three timepoints, data is collected: * before the medication review (T-1week) * during the review (Tweek 3) * after the review (Tweek12) The questionnaire provide data for the outcomes: medication related quality of life, adherence questionnaire, service satisfaction, use of emergency health services, self-management

Sponsors & Collaborators

  • Association of Belgian Pharmacies (APB)

    collaborator UNKNOWN

  • Joke Wuyts

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-08
Primary Completion
2017-10-11
Completion
2018-10-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03179722 on ClinicalTrials.gov